Seres Therapeutics
Price & Volume
Stats
See moreOpen | $5.43 |
Previous Close | $5.62 |
Day Range | $5.06-$5.43 |
52W Range | $5.31-$29.98 |
Market Cap | $59.1M |
Shares Short | 157,327 |
Financials
See moreRevenue (12 Mos) | $1.1M |
Revenue Growth (YoY) | -93.4% |
Gross Profit (12 Mos) | -$52.3M |
Diluted EPS | -$5.20 |
News
See moreYahoo Finance • last month
Seres Therapeutics Announces Two Transactions to Strengthen Balance Sheet, Reduce On-Going Lease Costs and Extend Projected Operating Cash Runway Well Into the First Quarter of 2027
Yahoo Finance • 2 months ago
Seres Therapeutics to Participate in H.C. Wainwright 4th Annual BioConnect Investor Conference
Yahoo Finance • 5 months ago
Sector Update: Health Care Stocks Rise Late Afternoon
Yahoo Finance • 5 months ago
Seres down after pausing investments for lead program
About
CEO | Mr. Richard N. Kender B.S., M.B.A. |
CFO | Ms. Marella Thorell CPA |
Address | 101 Cambridgepark Drive, Cambridge, MA, United States, 02140 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 66 |